>Year 2002, Issue 3
Zetina TH, Calderón M, Martínez E, Lozano V, Rentería MC, Zaldívar J, Villaseñor C
Left ventricular mechanical support with the Heart-Mate pneumatic implantable device in end-stage cardiac failure. Report of the first three cases in México
Rev Asoc Mex Med Crit y Ter Int 2002; 16 (3)
PDF: 126.62 Kb.
Introduction: End-stage cardiac failure is increasing each year and the posibilities of heart transplantation is limited in our country. The use of an implantable left ventricular device is a long-term therapeutic option for those patients.
Objective: To report the first cases treated with this procedure.
Design: Case report.
Setting: A surgery ICU of a general hospital of Mexico City.
Patients: Three male patients (31-53 yrs old) with end-stage cardiac failure.
Interventions: A left ventricular assist devices was implanted in abdomen.
Results: Two patients are still alive, both were extubated during the first 36 hours after procedure and they were discharged to home 21 days later. The more frequent complications were thoracic hemorrhage and difficulty for the epithelization of pneumatic outline wound. discharged to home 21 days after. The quality of life is better in the survivors and one patient is working as a teacher and gained 8 kg of weight in five months.
Conclusion: The lef ventricular assist device is an alternative option for the treatment of cardiac failure in patients waiting heart transplantation.
||Left ventricular mechanical support, Heart Mate IP, end-stage cardiac failure, heart transplantation, medical treatment.
2001 Heart and Stroke Statistical Update. Dallas: American Heart Association.
The SOLVD investigators. Effect of enalapril on survival inpatients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-02 (Abstract).
Packer M, Coats AJS, Fowler MB et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001;344:1651-1658.
Honsenpud JD, Bennett LE, Keck BM, Bouceck MM, Novick RJ. The registry of the International Society for Heart and Lung transplantation: seventeenth official report-2000;19: 909-931.
Frazier Oh, Rose EA, Macmanus Q et al. Multicenter clinical evaluation of the Heart-Mate 1000 IP left ventricular assist device. Ann Thorac Surg 1992;53:1080-1090.
Pennington Dg, McBride LR, Peigh PS, Miller LW, Swartz MT. Eight years´ experience with brodging to cardiac transplantation. J Thorac Cardiovasc Surg 1994;107:472-481.
Rose E, Gelijns A, Moscowitz A, Heitjan et al. Long Term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001;345(20):1435.
Igo Sr, Hibss CW, Trono R et al. Intra-aortic balloon pumping: theory and practice. Artif Organs 1978;2:249-56.
Goldstein DJ, Oz MC, Rose EA. Implantable left ventricular assist devices. N Engl J Med 1998;339: 522-1533.
Frazier OH, Duncan JM, Radovancevic B et al. Successful bridge to cardiac transplantation using a new left ventricular assist device. Presented at the Eleventh Annual Meeting and Scientific Sessions of the International Society of Heart Transplantation. Paris Francia, Abril 7-9,1991.
Dasse K, Chipman SD, Sherman CN, Levine AH, Frazier OH. Clinical experience with textured blood contacting surfaces in ventricular assist devices. ASAIO Trans 1987;10: 418-25.
Graham TR, Dasse K, Coumbe A, Salih V, Marrinan MT, Frazier OH et al. Neo-intimal developmet on textured biomaterial surfaces during clinical use an implantable left ventricular assist device. Eur J Cardiothorac Surg 1990;4: 182-90.
Frazier OH, Macris MP, Myers TJ et al. Improved survival after extended bridge to cardiac transplantation. Ann Thorac Surg 1994;57:1416-1422.
Myers TJ, Macris M. Clinical experience with the Heart Mate left ventricular assist device. Heart Failure. December 1994-January 2001. 247-258.
McCarthy P. HeartMate implantable left ventricular assist device: brigde to transplantation and future applications. Ann Thorac Surg 1995;59:S46-51.
O´Connell JB, Bristow MR, Economic impact of heart failure in the United States: time for a different approach. J Heart Lung Transplant 1994;13:S107-12.
Frazier Oh. New technologies in the treatment of severe cardiac failure: The Texas Heart Institute Experience. Ann Thorac Surg 1995;59:S31-38.
Burton N, Lefrak E, MacManus Q, Hill A, Marino J, Speir A, Akl B, Albus R, Massimiano P. A reliable bridge to cardiac transplantation: The TCI left ventricular assist device. Ann Thorac Surg 1993;55:1425-31.
Termuhlen DF, Swartz MT, Pennington DG et al. Tromboembolic complications with the Pierce Donachy ventricular assist device. ASAIO Trans 1989;35:616-18.
Frazier OH, Rose E, Mc Carthy P, Burton N, Tector A, Levin H, Kayne H, Poirier V, Dasse K. Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system. Annals of Surgery 1995;222:327-38.
El-Amir NG, Gardocki M, Levin HR et al. Gastrointestinal consequences of left ventricular assist device placement. ASAIO J 1996;42:150-153.
Garnfeldt H, Solem J, Lonn U, Peterzén B, Carnstam B, Dahlstrom U, Jansson K, Koul B, Steen S, Toom M, Rutberg H, Nylander E, Casimir-Ahn H. The Linkoping-Lung surgical experience with the Heartmate left ventricular assist system. Ann Thorac Surg 1995;59:S52-55.
McCarthy P, Nakatani S, Vargo R, Kottke-Marchant K, Harasaki H, James K, Savage R, Thomas J. Structural and left ventricular histologic changes after implantable LVAD insertion. Ann Thorac Surg 1995;59:609-13.
Levin H. Oz Mehmet, Chen J, Packer M, Rose E, Burkhoff D. Reversal of chronic ventricular dilatation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. Circulation 1995;91:2717-2720.
>Year 2002, Issue 3